Considering the centrality of TTR instability in the pathogenesis of cardiac amyloidosis, TTR levels have been used as a therapeutic target to evaluate the efficacy of disease-modifying therapy for TTR cardiac amyloidosis3. The gene discussed is TTR; the disease is cardiac amyloidosis.